The risk profile is well-characterized, with nausea, vomiting, and rare but serious risks including pancreatitis and gallbladder disease requiring monitoring
Scheme 5
It is not a GHRH analog it is a ghrelin mimetic, meaning it binds the ghrelin receptor (the same receptor activated by the hunger hormone)
As of the issuance of this order on August 25, 2025, the importation of APIs obtained through biotechnological processes - such as semaglutide and liraglutide - for compounding purposes was restricted to manufacturers whose APIs have been previously reviewed by ANVISA during the products registration process
41 Additionally, in retrospective cohort analyses also using the TriNetX database, both Chou et al and Abbass et al found no association between semaglutide use and risk of NAION
Observational data presented at ASCO 2026 suggested an association between GLP-1 use and lower metastatic progression in obesity-related cancers, including breast cancer
